达维塔保健（DVA）今日盘前股价大幅上涨7.10%，成为市场关注的焦点。
消息面上，该公司公布了超出华尔街预期的第一季度业绩，并基于肾透析服务需求的强劲与稳定增长，上调了全年调整后利润预期。具体而言，公司目前预计2026年经调整后每股收益将在14.10美元至15.20美元之间，高于此前预测的13.60美元至15.00美元。
财报数据显示，在截至3月31日的季度，该公司按调整后数据计算的每股盈利为2.87美元，高于分析师预期的2.32美元；季度营收达到34.2亿美元，也高于市场预期的33.6亿美元。这表明公司在应对患者护理和运营成本上涨的挑战后，业务已重拾增长势头，从而提振了投资者信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.